Developing early and improved diagnostic tests to lift ovarian cancer survival rates are the focus of two research projects commencing at The University of Queensland.
![](https://therapeuticinn.wpengine.com/wp-content/uploads/2023/07/image-12.png)
UQ scientists Associate Professor Paul Thomas and Professors John Hooper and Trent Munro, will test a new agent measuring its suitability in fighting epithelial ovarian cancer (EOC), in the first study of its kind in humans.